Phase III clinical trial of COVAXIN shows 81 per cent efficacy
COVAXIN has been developed on the WHO pre-qualified verocell platform, which is globally recognised with a well-established track…
Recover your password.
A password will be e-mailed to you.
- Advertisement -
Recover your password.
A password will be e-mailed to you.